The global antifungal agents market is anticipated to grow at a significant CAGR of nearly 3.5% through 2028, according to a report by Research & Markets. Antifungal agents prevent and destroy the growth of fungi that are responsible for several diseases such as aspergillosis, ringworm, and skin infection, among others. Antifungal drugs include azoles, polyenes, echinocandins, and allylamines.
Antifungal agents are a class of drugs that are used to detect and eliminate fungal infections from the body with minimal side effects. One factor contributing to the growth of the market includes the rising number of patients suffering from hygiene-related issues in emerging countries. However, the availability of alternative treatments is expected to hinder the growth of the market.
Another major factor contributing to the growth of the market is the rising incidences of fungal diseases. Fungal disease causes serious illness and death and many of them go undiagnosed.